Cabaletta Bio (CABA) Total Liabilities (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Total Liabilities of $53.0 million in Q4 2025, up 5.45% quarter-over-quarter from $50.3 million in Q3 2025, and up 62.12% on a YoY basis from $32.7 million in Q4 2024.
Cabaletta Bio (CABA) Total Liabilities (2018 - 2025) Analysis & Trends
Cabaletta Bio's Total Liabilities history runs 8 years deep, the most recent figure standing at $53.0 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 62.12% year-over-year to $53.0 million; the TTM figure through Dec 2025 stood at $53.0 million (up 62.12% YoY), while the FY2025 annual figure was $53.0 million, up 62.12% from the prior year.
- Total Liabilities was $53.0 million for Q4 2025 at Cabaletta Bio, up from $50.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $53.0 million in Q4 2025 to a low of $4.0 million in Q1 2021.
- Historically, Total Liabilities has averaged $20.0 million across 5 years, with a median of $12.4 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities declined 3.69% in 2022, then soared 157.1% in 2025.
- A 5-year view of Total Liabilities shows it stood at $8.4 million in 2021, then soared by 48.54% to $12.4 million in 2022, then surged by 40.2% to $17.5 million in 2023, then jumped by 87.43% to $32.7 million in 2024, then surged by 62.12% to $53.0 million in 2025.
- The last three Total Liabilities figures came in at $53.0 million (Q4 2025), $50.3 million (Q3 2025), and $46.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | 53.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.03 Mn |
| Sep 30, 2025 | 50.29 Mn |
| Jun 30, 2025 | 46.02 Mn |
| Mar 31, 2025 | 43.59 Mn |
| Dec 31, 2024 | 32.71 Mn |
| Sep 30, 2024 | 30.17 Mn |
| Jun 30, 2024 | 17.90 Mn |
| Mar 31, 2024 | 18.74 Mn |
| Dec 31, 2023 | 17.45 Mn |
| Sep 30, 2023 | 12.36 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 11.80 Mn |
| Dec 31, 2022 | 12.45 Mn |
| Sep 30, 2022 | 5.80 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 8.38 Mn |
| Sep 30, 2021 | 6.02 Mn |
| Jun 30, 2021 | 5.60 Mn |
| Mar 31, 2021 | 3.97 Mn |